Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 258,718 | 129,866 | 241,925 | 235,260 | 298,843 |
| Marketable Securities | 717,716 | 649,568 | 660,369 | 848,577 | 902,149 |
| Receivables | 14,651 | 10,523 | 6,227 | 865 | N/A |
| Inventories | 20,156 | 8,644 | 3,849 | 3,020 | N/A |
| Other current assets | 24,839 | 20,316 | 26,980 | 21,239 | 24,792 |
| TOTAL | $1,036,080 | $818,917 | $939,350 | $1,108,961 | $1,225,784 |
| Non-Current Assets | |||||
| PPE Net | 16,046 | 16,867 | 17,185 | 17,540 | 17,900 |
| Investments And Advances | 3,559 | 4,565 | 3,353 | 3,465 | 1,882 |
| Intangibles | 14,138 | 14,397 | 14,655 | 14,914 | 0 |
| Other Non-Current Assets | 59,885 | 60,297 | 59,218 | 57,767 | 57,518 |
| TOTAL | $93,628 | $96,126 | $94,411 | $93,686 | $77,300 |
| Total Assets | $1,129,708 | $915,043 | $1,033,761 | $1,202,647 | $1,303,084 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 37,961 | 32,507 | 22,320 | 38,861 | 19,452 |
| Accrued Expenses | 99,418 | 107,483 | 102,280 | 120,587 | 107,534 |
| TOTAL | $137,379 | $139,990 | $124,600 | $159,448 | $126,986 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 45,864 | 46,102 | 46,531 | 46,683 | 47,044 |
| TOTAL | $45,864 | $46,102 | $46,531 | $46,683 | $47,044 |
| Total Liabilities | $183,243 | $186,092 | $171,131 | $206,131 | $174,030 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,148 | 58,604 | 58,187 | 58,038 | 57,587 |
| Common Shares | 70 | 58 | 58 | 58 | 58 |
| Retained earnings | -2,976,292 | -2,814,388 | -2,637,475 | -2,452,889 | -2,250,414 |
| Other shareholders' equity | -1,550 | -1,715 | -1,707 | -3,719 | -6,129 |
| TOTAL | $946,465 | $728,951 | $862,630 | $996,516 | $1,129,054 |
| Total Liabilities And Equity | $1,129,708 | $915,043 | $1,033,761 | $1,202,647 | $1,303,084 |